2-Methyl-2H-indazol-6-amine, 95.0%, 250mg

5-Bromo-1-methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole, 98%, 100mg

1-[(2r)-2-(hydroxymethyl)pyrrolidin-1-yl]ethan-1-one, 97%, 250mg

N,N-dimetilformammide, minimo 99,5%, per sintesi, 2,5 l, confezione in plastica.

1-(2,3-Dihydro-1H-indol-5-yl)-ethanone, 95.0%, 100mg

Guanylthiourea>98.0%(HPLC)(T)25g

Acid Red 18>85.0%(E)25g

3-(2-fluorophenoxy)azetidine hydrochloride, 95.0%, 250mg

3,5-Dimethoxybenzonitrile, 95.0%, 10g

ethyl 5-(4-ethylphenyl)-1H-pyrazole-3-carboxylate, 95.0%, 2g

4-Bromo-2-methoxyphenol, 98.0%, 500g

tert-butyl 4-(azidomethyl)piperidine-1-carboxylate, 95.0%, 1g

4-Bromo-3-(trifluoromethyl)phenol>98.0%(GC)5g